Trial · NCT03395314
Results by group210
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 210
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Suicidal Thoughts as Measured by Item 10 on the Montgomery-Asberg Depression Scale (MADRS) | Midazolam | baseline | 2.66 | Standard Error 0.37 | units on a scale |
| Change in Suicidal Thoughts as Measured by Item 10 on the Montgomery-Asberg Depression Scale (MADRS) | Low Dose Ketamine | baseline | 2.7 | Standard Error 0.41 | units on a scale |
| Change in Suicidal Thoughts as Measured by Item 10 on the Montgomery-Asberg Depression Scale (MADRS) | Midazolam | 1hr post-infusion | 0.0 | Standard Error 0.37 | units on a scale |
| Change in Suicidal Thoughts as Measured by Item 10 on the Montgomery-Asberg Depression Scale (MADRS) | Low Dose Ketamine | 1hr post-infusion | 0.1 | Standard Error 0.41 | units on a scale |
| Change in Suicidal Thoughts as Measured by Item 10 on the Montgomery-Asberg Depression Scale (MADRS) | Midazolam | Day 1 post-infusion | 0.59 | Standard Error 0.38 | units on a scale |
| Change in Suicidal Thoughts as Measured by Item 10 on the Montgomery-Asberg Depression Scale (MADRS) | Low Dose Ketamine | Day 1 post-infusion | 0.5 | Standard Error 0.41 | units on a scale |
| Change in Suicidal Thoughts as Measured by Item 10 on the Montgomery-Asberg Depression Scale (MADRS) | Midazolam | Day 3 post-infusion | 0.89 | Standard Error 0.38 | units on a scale |
| Change in Suicidal Thoughts as Measured by Item 10 on the Montgomery-Asberg Depression Scale (MADRS) | Low Dose Ketamine | Day 3 post-infusion | 0.7 | Standard Error 0.41 | units on a scale |
| Change in Suicidal Thoughts as Measured by Item 10 on the Montgomery-Asberg Depression Scale (MADRS) | Midazolam | Day 7 post-infusion | 0.83 | Standard Error 0.37 | units on a scale |
| Change in Suicidal Thoughts as Measured by Item 10 on the Montgomery-Asberg Depression Scale (MADRS) | Low Dose Ketamine | Day 7 post-infusion | 0.8 | Standard Error 0.41 | units on a scale |
| Change in Suicidal Thoughts as Measured by Item 10 on the Montgomery-Asberg Depression Scale (MADRS) | Midazolam | Day 14 post-infusion | 1.66 | Standard Error 0.37 | units on a scale |
| Change in Suicidal Thoughts as Measured by Item 10 on the Montgomery-Asberg Depression Scale (MADRS) | Low Dose Ketamine | Day 14 post-infusion | 1.3 | Standard Error 0.41 | units on a scale |
| Change in Suicidal Thoughts as Measured by Item 10 on the Montgomery-Asberg Depression Scale (MADRS) | Midazolam | Day 28 post-infusion | 1.29 | Standard Error 0.4 | units on a scale |
| Change in Suicidal Thoughts as Measured by Item 10 on the Montgomery-Asberg Depression Scale (MADRS) | Low Dose Ketamine | Day 28 post-infusion | 2.6 | Standard Error 0.42 | units on a scale |
| Change in Suicidality as Measured by the Columbia Suicide Severity Rating Scale (C-SSRS) | Midazolam | baseline | 1.58 | Standard Error 0.31 | score on a scale |
| Change in Suicidality as Measured by the Columbia Suicide Severity Rating Scale (C-SSRS) | Low Dose Ketamine | baseline | 1.9 | Standard Error 0.34 | score on a scale |
| Change in Suicidality as Measured by the Columbia Suicide Severity Rating Scale (C-SSRS) | Midazolam | 1hr post-infusion | 0 | Standard Error 0.31 | score on a scale |
| Change in Suicidality as Measured by the Columbia Suicide Severity Rating Scale (C-SSRS) | Low Dose Ketamine | 1hr post-infusion | 0.0 | Standard Error 0.34 | score on a scale |
| Change in Suicidality as Measured by the Columbia Suicide Severity Rating Scale (C-SSRS) | Midazolam | Day 1 post-infusion | 0 | Standard Error 0.31 | score on a scale |
| Change in Suicidality as Measured by the Columbia Suicide Severity Rating Scale (C-SSRS) | Low Dose Ketamine | Day 1 post-infusion | 0.0 | Standard Error 0.34 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03395314/results